Skip to main content
Erschienen in: Clinical Rheumatology 1/2010

01.01.2010 | Case Report

Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report

verfasst von: Sung-Won Lee, Sang-Yeob Lee, Ki-Nam Kim, Jin-Kyu Jung, Won-Tae Chung

Erschienen in: Clinical Rheumatology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Behςet’s disease (BD) is a multisystem disorder characterized by vasculitis. Pulmonary vascular problems such as pulmonary artery aneurysms (PAA) are reported to indicate poor prognosis and high mortality. We describe a 43-year-old man who presented with life threatening bilateral PAA and thromboembolic disease due to BD. He was treated with prednisone and pulse cyclophosphamide and was poorly responsive to the conventional immunosuppression. The introduction of adalimumab therapy stabilized his PAA. We report that the inhibition of TNF-α using the neutralizing monoclonal antibody adalimumab has the potential to induce rapid, complete, and long-lasting remission in a life-threatening manifestation of BD.
Literatur
1.
Zurück zum Zitat International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
2.
Zurück zum Zitat Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291CrossRefPubMed Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291CrossRefPubMed
3.
Zurück zum Zitat Baki K, Villiger PM, Jenni D, Meyer T, Beer JH (2006) Behçet’s disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment. Ann Rheum Dis 65:1531–1532CrossRefPubMed Baki K, Villiger PM, Jenni D, Meyer T, Beer JH (2006) Behçet’s disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment. Ann Rheum Dis 65:1531–1532CrossRefPubMed
4.
Zurück zum Zitat Lie JT (1992) Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 19:341–343PubMed Lie JT (1992) Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 19:341–343PubMed
5.
Zurück zum Zitat Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S et al (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19:402–410PubMed Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S et al (1992) Vascular involvement in Behçet’s disease. J Rheumatol 19:402–410PubMed
6.
Zurück zum Zitat Hamuryudan V, Er T, Seyahi E, Akman C, Tuzun H, Fresko I, Yurdakul S, Numan F, Yazici H (2004) Pulmonary artery aneurysms in Behçet syndrome. Am J Med 117:867–870CrossRefPubMed Hamuryudan V, Er T, Seyahi E, Akman C, Tuzun H, Fresko I, Yurdakul S, Numan F, Yazici H (2004) Pulmonary artery aneurysms in Behçet syndrome. Am J Med 117:867–870CrossRefPubMed
7.
Zurück zum Zitat Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behçet disease: a cumulative analysis. Chest 127:2243–2253CrossRefPubMed Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behçet disease: a cumulative analysis. Chest 127:2243–2253CrossRefPubMed
8.
Zurück zum Zitat Uzun O, Erkan L, Akpolat I, Findik S, Atici AG, Akpolat T (2008) Pulmonary involvement in Behçet’s disease. Respiration 75:310–321CrossRefPubMed Uzun O, Erkan L, Akpolat I, Findik S, Atici AG, Akpolat T (2008) Pulmonary involvement in Behçet’s disease. Respiration 75:310–321CrossRefPubMed
9.
Zurück zum Zitat Hamuryudan V, Yurdakul S, Moral F, Numan F, Tuzun H, Tuzuner N, Mat C, Tuzun Y, Ozyazgan Y, Yazici H (1994) Pulmonary arterial aneurysms in Behçet’s syndrome: a report of 24 cases. Br J Rheumatol 33:48–51CrossRefPubMed Hamuryudan V, Yurdakul S, Moral F, Numan F, Tuzun H, Tuzuner N, Mat C, Tuzun Y, Ozyazgan Y, Yazici H (1994) Pulmonary arterial aneurysms in Behçet’s syndrome: a report of 24 cases. Br J Rheumatol 33:48–51CrossRefPubMed
10.
Zurück zum Zitat Tunaci M, Ozkorkmaz B, Tunaci A, Gul A, Engin G, Acunas B (1999) CT findings of pulmonary artery aneurysms during treatment for Behçet’s disease. AJR Am J Roentgenol 172:729–733PubMed Tunaci M, Ozkorkmaz B, Tunaci A, Gul A, Engin G, Acunas B (1999) CT findings of pulmonary artery aneurysms during treatment for Behçet’s disease. AJR Am J Roentgenol 172:729–733PubMed
11.
Zurück zum Zitat Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS (2002) Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet’s disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 130:46–54CrossRefPubMed Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS (2002) Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet’s disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol 130:46–54CrossRefPubMed
12.
Zurück zum Zitat Evereklioglu C (2005) Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50:297–350CrossRefPubMed Evereklioglu C (2005) Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50:297–350CrossRefPubMed
13.
Zurück zum Zitat van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM (2007) Adalimumab: a new modality for Behçet’s disease? Ann Rheum Dis 66:565–566CrossRefPubMed van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM (2007) Adalimumab: a new modality for Behçet’s disease? Ann Rheum Dis 66:565–566CrossRefPubMed
Metadaten
Titel
Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report
verfasst von
Sung-Won Lee
Sang-Yeob Lee
Ki-Nam Kim
Jin-Kyu Jung
Won-Tae Chung
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 1/2010
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1272-2

Weitere Artikel der Ausgabe 1/2010

Clinical Rheumatology 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.